✦ LIBER ✦

Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats (GEPRs)

✍ Scribed by Pietro Gareri; Daniele Condorelli; Natale Belluardo; Emilio Russo; Antonella Loiacono; Vincenza Barresi; Angela Trovato-Salinato; Melita B. Mirone; Guido Ferreri Ibbadu; Giovambattista De Sarro

Book ID: 116784202
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 372 KB
Volume: 47
Category: Article
ISSN: 0028-3908
DOI: 10.1016/j.neuropharm.2004.08.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to “Anticonvulsant effects o

Corrigendum to “Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats (GEPRs)”[Neuropharmacology 47 (2004) 1205-1216]

✍ Pietro Gareri; Daniele Condorelli; Natale Belluardo; Emilio Russo; Antonella Loi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Genetically Epilepsy-Prone Rats (GEPRs)

Genetically Epilepsy-Prone Rats (GEPRs) in Drug Research

✍ Phillip C. Jobe; John W. Dailey 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Brain ion concentrations and water conte

Brain ion concentrations and water content in genetically epilepsy-prone rats (GEPRs).

✍ SAIJA, 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Some quinolones potentiate aminophylline

Some quinolones potentiate aminophylline-induced seizures in genetically epilepsy prone rats (GEPRs)

✍ De Sarro, A.; Trimarchi, G.R.; De Sarro, G.B. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Anticonvulsant effect of enhancement of

Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): a microinjection study

✍ Qing-Shan Yan; John W Dailey; Jennifer L Steenbergen; Phillip C Jobe 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 752 KB

Acute and chronic anticonvulsant effects

Acute and chronic anticonvulsant effects of d(−)CPPene in genetically epilepsy-prone rats

✍ Stuart E. Smith; Astrid G. Chapman 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 667 KB

Acute administration (0.4-12 mumol/kg, i.p.) of the NMDA antagonist D(-)CPPene (3-(2-carboxypiperazin-4-yl)propenyl-1-phosphonic acid; molecular weight = 250.2) dose-dependently reduced the incidence of sound-induced clonic seizures in genetically epilepsy-prone (GEP) rats. The ED50 value against cl